Hurthle cell tumor dwelling in hot thyroid nodules: Preoperative detection with technetium-99m-MIBI dual-phase scintigraphy

Journal of Nuclear Medicine

Volumn 39, Issue 5, 1998, Pages 822-825

  Vattimo, Angelo ^a   Bertelli, Paolo ^a   Cintorino, Marcella ^a   Burroni, Luca ^a   Volterrani, Duccio ^a   Vella, Alessandra ^a   Lazzi, Stefano ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Hot nodules; Hurthle cells tumor; Technetium 99m sestamibi; Thyroid scintigraphy

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; EUTHYROIDISM; FEMALE; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; MALE; ONCOCYTOMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THYROID ADENOMA; THYROID CARCINOMA; THYROID NODULE; THYROID SCINTISCANNING; THYROIDECTOMY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; THYROID GLAND; THYROID TUMOR;

ADENOMA, OXYPHILIC; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE;

EID: 0031596982     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Werk EE, Vernon BM, Gonzalez et al. Cancer in thyroid nodules. A community hospital survey. Arch Intern Med 1984;144:474-476.
2. Belfiore A, Giuffrida D, La Rosa GL, et al. High frequency of cancer in cold thyroid nodules occurring at young age. Acta Endocrinol 1989;121:197-202.
3. Steinberg M, Cavalieri RR, Choy SH. Uptake of technetium-99m-pertechnetate in a primary thyroid carcinoma: need for caution in evaluating nodules. J Clin Endocrinol 1970;31:81-84.
4. 131I uptake: case report. J Nucl Med 1976;17:22-23.
5. Quinn JL, Henkin RE. Scanning techniques to assess thyroid nodules. Ann Rev Med 1975;26:193-201.
6. 99mTc-pertechnetate in thyroid carcinomas to explain a scan discrepancy: case report. J Nucl Med 1977;18:796-798.
7. Demeester-Mirkine N, Van Sande J, Corvilain J, Durnont JE. Benign thyroid nodule with normal iodide trap and defective organification. J Clin Endocrinol Metab 1975;41:1169-1171.
8. 99mTc-pertechnetate and radioiodine. Radiology 1976;119:737-739.
9. 99mTc and radioactive iodine. JAMA 1974;228:866-869.
10. 131I in thyroid nodules: case report. J Nucl Med 1977;18:346-347.
11. Massin JP, Planchon C, Accard JL, Perez R. Discordances scintigraphiques entrele technetium 99m et l'iode 131 dans l'etude des nodules thyroidiens. Nouvelle Presse Med 1977;6:97-100.
12. 131I in thyroid scanning. Eur J Nucl Med 1982;7:444-446.
13. Kusic Z, Becker DV, Saenger EL, et al. Comparison of technetium-99m and iodine-123 imaging of thyroid nodules: correlation with pathological findings. J Nucl Med 1990;31:393-399.
14. David E, Rosen IB, Bain J, James J. Management of the hot thyroid nodule. Am J Surg 1995;170:481-483.
15. Siddiqui AR, Karanauskas S. Hürthle cell carcinoma in an autonomous thyroid nodule in an adolescent. Pediatr Radiol 1995;25:568-569.
16. Caplan RH, Abellera RM, Kisken WA. Hürthle cell neoplasms of the thyroid gland: reassessment of functional capacity. Thyroid 1994;4:243-248.
17. Rosen IB, Luk S, Katz I. Hürthle cell tumor behavior: dilemma and resolution. Surgery 1985;98:777-783.
18. Gosain AK, Clark OH. Hürthle cell neoplasm: malignant potential. Arch Surg 1984;119:515-519.
19. Saull SC, Kimmelman CP. Hürthle cell tumor of the thyroid gland. Oiolaryngol Head Neck Surg 1985;93:58-62.
20. Gonzalez-Campora R, Herrero-Zapatero A, Lerma E, et al. Hürthle cell and mitochondria-rich cell tumors: a clinicopathological study. Cancer 1986;57:1154-1163.
21. Arganini M, Behar R, Wu TC, Straus F, et al. Hürthle cell tumors: a 25-year experience. Surgery 1986;100:1108-1114.
22. Bronner MP, LiVolsi VA. Oxyphilic (Askanazy/Hürthle cell) tumours of the thyroid: microscopic features predict biologic behavior. Surg Pathol 1988;1:137-150.
23. Grant CS, Barr D, Goellner JR, et al. Benign Hürthle cell rumours of the thyroid: a diagnosis to be trusted? World J Surg 1988;12:488-495.
24. Carvalho PA, Chiu ML, Kronauge JF, et al. Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 1992;33:1516-1521.
25. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential-dependence. Circulation 1990;82:1826-1838.
26. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblasts. J Nucl Med 1990;31:1646-1653.
27. Rosai J, Carcangiu ML, Delellis RA. Tumors with oncocytic features (Hürthle cell rumors). In: Rosai J, Carcangiu ML, Delellis RA, eds. Tumors of the Thyroid Gland, third series, fasicle 5. Armed Forces Institute of Pathology, Washington, D.C., 1992:161-180.
28. LiVolsi VA. Hürthle cell lesions. In: LiVolsi VA, ed. Surgical pathology of the thyroid. Philadelphia: W.B. Saunders; 1990:275-288.
29. Johnson TL, Lloyd RV, Buruey RE, et al. Hürthle cell thyroid tumors: an immuno-histochemical study. Cancer 1987;59:107-112.
30. Albores-Saaveda J, Nadji M, Civantos, et al. Thyroglobulin in carcinoma of the thyroid: an immunohistochemical study. Hum Pathol 1983;14:62-66.
31. Dekeyser L, Holyfield L, VanHerle A, et al. Biochemical and immunohistochemical characterization of proteins in Hürthle cell carcinoma. J Endocrinol Invest 1984;7: 449-454.
32. Vattimo A, Bertelli P, Cintorino M, et al. Identification of Hürthle cell tumor by single-injection, double-phase scintigraphy with technetium-99m-sestamibi. J Nucl Med 1995;36:778-782.
33. Vattimo A, Bertelli P, Cintorino M, et al. Double-phase technetium-99m-sestamibi scanning to evaluate nodular thyroid malignancy. J Nucl Med 1996;37:1919-1920.
34. 99mTc-pertechnetate scintigraphy after TSH stimulation. J Nucl Biol Med 1992;36:315-318.
35. Gundry SR, Burney RE, Thompson NW, et al. Total thyroidectomy for Hürthle cell neoplasm of the thyroid. Arch Surg 1983:;18:529-532.
36. Thompson NW, Dunn EL, Batsakis JG, et al. Hürthle cell lesions of the thyroid gland. Surg Gynecol Obstet 1974;139:555-560.
37. Miller RH, Estrada R, Sneed WF, et al. Hürthle cell tumors of the thyroid gland. Laryngoscope 1983;93:884-886.
38. McDonald RJ, Wu S, Jensen JL, et al. Malignant transformation of a Hürthle cell tumor: case report and survey of the literature. J Nucl Med 1991;32:1266-1269.
39. Rossi RL, Nieroda C, Cady B, et al. Malignancies of the thyroid gland: the Lahey clinic experience. Surg Clin N Am 1985;65:211-230.
40. Har-El G, Hadar T, Levy R, et al. Hürthle cell carcinoma of the thyroid gland: a tumor of moderate malignancy. Cancer 1986;57:1613-1617.
41. 131I therapy in the management of thyroid cancer: a prospective story. Cancer 1977;40:195-202.
42. Frazell EL, Duffy BR. Hürthle cell cancer of the thyroid: a review of 40 cases. Cancer 1951;4:952-956.
43. Tollefsen HR, Shah JP, Huvos AG. Hürthle cell carcinoma of the thyroid. Am J Surg 1975;130:390-394.
44. McLeod MK. Hürthle cell neoplasm of the thyroid. Otolarygnol Clin NA 1990;23: 441-452.
45. Samaan NA, Shultz PN, Haynie TP, et al. Pulmonary matastasis of differentiated thyroid carcinoma: treatment results in 101 patients. J Clin Endocrinol Metab 1985;60:376-380.
46. Hamann A, Gratz K, Soudah B, et al. Szintigraphie mit 131-J bei oxyphilen Karzinomen der Schilddruse. Nuklearmedizin 1994;33:219-223.
47. Vergara E, Lastoria S, Varrella P, et al. Technetium-99m-pentavalent dimercaptosuccinic acid uptake in Hürthle cell tumor of the thyroid. J Nucl Biol Med 1993;37:65-68.
48. Yen T, Lin H, Lee C, et al. The role of technetium-99m sestamibi whole body scans in diagnosing metastatic Hürthle cell carcinoma of the thyroid gland after total thyroidectomy: a comparison with iodine-131 and thallium-201 whole body scans. Eur J Nucl Med 1994;21:980-983.
49. 99mTc-MIBI. Clin Nucl Med 1991;16:812-814.